Amphastar Pharmaceuticals

Amphastar Pharmaceuticals
Traded as NASDAQ: AMPH
S&P 600 Component

Amphastar Pharmaceuticals is a publicly traded American pharmaceutical company.[1] Its products include Enoxaparin Sodium Injection, Cortrosyn, Amphadase, Emergency Syringes in Luer-Jet, Lidocaine, Naloxone, and Phytonadione Injection.[2][3]

Controversies

Amphastar has been criticized for its pricing of naloxone, a drug that treats opioid overdose.[4]

References

  1. ↑ "Amphastar Pharmaceuticals, Inc. (AMPH)". NASDAQ.com. NASDAQ OMX Group. Retrieved 3 January 2016.
  2. ↑ Dions, Don. "Amphastar Pharmaceuticals IPO Could Be A Star Among Biotech Stocks". Seeking Alpha. Retrieved 3 January 2016.
  3. ↑ "Products". amphastar.com. Retrieved 3 January 2016.
  4. ↑ Collins, Sam. "Pharmaceutical Company With Monopoly On Lifesaving Treatment Jacks Up Prices". ThinkProgress.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.